News

Facility brings advanced genetic testing capabilities to West Bengal, including prenatal, oncology, and rare disease ...
SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles ...
Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...
Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...
Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...
While it is accepted that extracellular vesicles (EVs)-mediated transfer of microRNAs contributes to intercellular communication, the knowledge about molecular mechanisms controlling the selective and ...
Introduction In vitro diagnostics (IVD) refers to medical tests performed outside the human body, typically in laboratories or at the point of ...
The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...
A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy ...
The global DNA Sequencing Services Market is estimated to be valued at USD 1.1 billion in 2025 and is projected to reach USD 2.5 billion by 2035, registering a compound annual growth rate of 8.7% over ...